(Q48239186)
Statements
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma (English)
P A Burch
S Nair
R P Dinapoli
B Scheithauer
J R O'Fallon
P S Etzell
J M Leitch
R F Morton